Browse

CYP3A5*1 Allele: Impacts on Early Acute Rejection and Graft Function in Tacrolimus-Based Renal Transplant Recipients

Cited 32 time in Web of Science Cited 32 time in Scopus
Authors
Min, Sang-Il; Kim, Seong Yup; Ahn, Sang Hyun; Min, Seung-Kee; Kim, Yon Su; Oh, Jung Mi; Ha, Jongwon; Kim, Sang Joon; Moon, Kyung Chul; Kim, Si Hwa
Issue Date
2010-12-27
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Citation
TRANSPLANTATION; Vol.90 12; 1394-1400
Keywords
CYP3A5Acute rejectionTacrolimusRenal transplantationPharmacogenetics
Abstract
Background. Tacrolimus is a major immunosuppressant, which has a narrow therapeutic range and wide interindividual variation. The effects of genetic polymorphisms of cytochrome P450 3A (CYP3A) 5 and Adenosine triphosphate-binding cassette subfamily B member 1 (ABCB1) genes on the achievement of target tacrolimus trough levels and clinical outcomes in renal transplants were evaluated. Methods. A total of 62 patients participated in this prospective study. After an initial fixed oral dose (0.08 mg/kg two times per day), tacrolimus doses were adjusted to a target range based on daily measurement of blood trough concentration. Every patient underwent 10-day scheduled biopsy. Both the patients and investigators were blinded for the genetic polymorphisms. Results. Those subjects expressing CYP3A5 (n = 29) evidenced significantly lower tacrolimus trough levels between days 1 and 5 after transplantation, when compared with nonexpressers (n = 33). Significantly higher overall incidences of early T-cell-mediated rejection (TCR) of at least Banff grade 1 inseverity (P = 0.017), including clinical rejection within 10 days and subclinical rejection in biopsies at postoperative day 10 were detected in CYP3A5 expressers. The severity of TCR according to Banff`07 classification was associated with CYP3A5 genotypes (P = 0.012). Moreover, multivariate analysis identified CYP3A5 expression as an independent risk factor for TCR (odds ratio: 2.79; P = 0.043). Significantly lower estimated glomerular filtration rates until 1 month and numerically lower estimated glomerular filtration rates by 12 months were noted in the CYP3A5 expressers. The genetic polymorphisms of the ABCB1 genes exerted no significant effects. Conclusion. We confirmed the significant effects of CYP3A5 polymorphism on the achievement of target tacrolimus trough levels and the development of acute rejection in early period after transplantation and consequent renal allograft function.
ISSN
0041-1337
Language
English
URI
http://hdl.handle.net/10371/77721
DOI
https://doi.org/10.1097/TP.0b013e3181fa93a4
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse